Chung-Shien Lee

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 19

Top Topics

Prostate Cancer

Tyrosine Kinase

Radical Prostatectomy

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Clinical Medicine Insights. Oncology

Journal of pharmacy practice

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Chung-Shien Lee, So Yi Lam, Angel W Liu, Cristina Sison, Xin-Hua Zhu
A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer. Clinical Medicine Insights. Oncology 17 (2023)
Chung-Shien Lee, Kevin Sullivan
Alectinib-induced hemolytic anemia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Chung-Shien Lee, So Yi Lam, Angel W Liu, Cristina Sison, Xin-Hua Zhu
A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer. Clinical Medicine Insights. Oncology 17 (2023)
Madison Fraser, Nagashree Seetharamu, Matthew Diamond, Chung-Shien Lee
Profile of Capmatinib for the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Patient Selection and Perspectives. Cancer management and research 15 (2023)
Jonathan Wang, Chung-Shien Lee, Shirin Attarian, Nina Kohn, Craig Devoe
Inpatient utilization of immune checkpoint inhibitors and clinical outcomes. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
Chung-Shien Lee, Jennifer Hernandez, Connie Liang, Ashley Leung, Dimitre G Stefanov, Kit Cheng, Veena John
A Real World Perspective of PARP Inhibitor Use in Gynecological Cancer Patients. Journal of pharmacy practice (2022)
Coral Olazagasti, Chung-Shien Lee, Angel W Liu, Dimitre Stefanov, Kit Cheng
A deep dive into CDK4/6 inhibitors: Evaluating real world toxicities and treatment paradigms in the elderly population. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Chung-Shien Lee, Iman Ahmed, Emily Miao, Shirley Chung, Khilna Patel, Nina Kohn, Nagashree Seetharamu
A real world analysis of first line treatment of advanced EGFR mutated non-small cell lung cancer: A multi-center, retrospective study. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Chung-Shien Lee, Emily Miao, Kasturi Das, Nagashree Seetharamu
Clinical efficacy with dabrafenib and trametinib in a T599_V600insT poorly differentiated metastatic thyroid carcinoma. BMJ case reports 14 (8) (2021)
Kevin Y Wang, James Newman, Chung-Shien Lee, Nagashree Seetharamu
Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer. SAGE open medicine 9 (2021)
Angel W Liu, Connie Liang, Chung-Shien Lee
A contemporary review of rearranged during transfection-selective inhibitors. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 28 (1) (2021)
Chung-Shien Lee, Matthew Milone, Nagashree Seetharamu
Osimertinib in EGFR-Mutated Lung Cancer: A Review of the Existing and Emerging Clinical Data. OncoTargets and therapy 14 (2021)
Chung-Shien Lee, Sandhya Sharma, Emily Miao, Cheryl Mensah, Kevin Sullivan, Nagashree Seetharamu
A Comprehensive Review of Contemporary Literature for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer and Their Toxicity. Lung Cancer (Auckland, N.Z.) 11 (2020)
Chung-Shien Lee, Rimda Wanchoo, Nagashree Seetharamu
Lorlatinib induced proteinuria: A case report. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (4) (2020)
Chung-Shien Lee, Craig E Devoe, Xinhua Zhu, Joanna Stein Fishbein, Nagashree Seetharamu
Pretreatment nutritional status and response to checkpoint inhibitors in lung cancer. Lung cancer management 9 (2) (2020)
Emily Miao, Nagashree Seetharamu, Kevin Sullivan, Stephen Eng, Chung-Shien Lee
Impact of Tyrosine Kinase Inhibitor Starting Dose on Outcomes in Patients With Non-Small Cell Lung Cancer. Journal of pharmacy practice 34 (1) (2019)
Stephen Eng, Chung-Shien Lee, Seungjun Ahn, Amy Sharma
A retrospective analysis of tumor lysis syndrome management in a quaternary care hospital. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (2) (2019)
So Yi Lam, Chung-Shien Lee, Sandhya Sharma, Kit Cheng
Bevacizumab-induced dysphonia: A case report with brief review of literature. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (4) (2019)
Kevin Sullivan, Chung-Shien Lee
Pemetrexed-induced severe rhabdomyolysis in lung cancer: A case report. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 25 (8) (2018)